EWTX — Edgewise Therapeutics Share News
0.000.00%
Last trade - 00:00Edgewise Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Edgewise Therapeutics Q2 net loss widens on higher expenses
Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
Edgewise shares slip after heart-disease drug trial data disappoints investors
Edgewise reports mid-stage trial data for heart disease drug, shares fall
U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood
Edgewise reports mid-stage trial data for heart disease drug, shares fall
U.S. RESEARCH ROUNDUP-Chipotle Mexican Grill, Honeywell, Tesla
Brief: Edgewise Therapeutics Reports Inducement Grants As Permitted By Nasdaq Listing Rules
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik
U.S. STOCKS ON THE MOVE-Grail, Kohl, Virgin Galactic
U.S. STOCKS ON THE MOVE-Apple, JetBlue, Cognizant
Edgewise surges on sale of muscle dystrophy business to Servier
Deals of the day-Mergers and acquisitions